Results 211 to 215 of about 19,784 (215)

Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor

Bioorganic and Medicinal Chemistry, 2011
Motohiro Takeda
exaly  

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

Current Medical Research and Opinion, 2008
Pablo Aschner, Avraham Karasik
exaly  

Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes

International Journal of Molecular Sciences, 2019
Poonam Kalhotra, Guillermo Osorio-Revilla, Veera Chandra Sekhar Reddy Chittepu   +2 more
exaly  

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2013
exaly  

A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes

Experimental and Clinical Endocrinology and Diabetes, 2011
exaly